Renton, WANCT07518004Now EnrollingIRB Ready

Diabetes Clinical Trial in Renton, WA

Access cutting-edge diabetes treatment through this clinical trial at a research site in Renton. Study-provided care at no cost to qualified participants.

Sponsored by Senseonics, Inc.

Quick Self-Assessment

See if you qualify for this Renton location

Preparing your pre-screening questions…

Expert Care in Renton

Access diabetes specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related diabetes treatment provided free

Apply for This Renton Location

Check if you qualify for this diabetes clinical trial in Renton, WA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Renton

    Convenient for WA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Renton site if eligible
  4. 4Begin participation

About This Diabetes Study in Renton

The purpose of this clinical investigation is to demonstrate that the proposed physical changes to the ROME GS Sensor do not have any adverse impact on safety and performance when compared to the Eversense 365 Sensor.

Sponsor: Senseonics, Inc.

Who Can Participate

Inclusion Criteria

Subjects meeting all of the following inclusion criteria will be included in this study:
Subjects ≥18 years of age
Clinically confirmed diagnosis of diabetes mellitus for ≥1 year
Subject has signed an informed consent form (ICF) and is willing to comply with protocol requirements

Exclusion Criteria

Subjects meeting any of the following exclusion criteria at the time of screening will be excluded from this study:
History of unexplained severe hypoglycemia in the previous 6 months. Severe hypoglycemia is defined as hypoglycemia resulting in loss of consciousness or seizure
History of diabetic ketoacidosis requiring emergency room visit or hospitalization in the previous 6 months
Subjects with gastroparesis
Female subjects of childbearing capacity (defined as of childbearing age and as not surgically sterile or not menopausal for ≥ 1 year) who are lactating or pregnant, intending to become pregnant, or not practicing birth control during the course of the study.
A condition preventing or complicating the placement, operation or removal of the Sensor or wearing of transmitter, including upper extremity deformities or skin condition
Symptomatic coronary artery disease; unstable angina; myocardial infarction, transient ischemic attack or stroke within 6 months; uncontrolled hypertension (systolic\>160 mm HG or diastolic \>100 mm Hg at time of screening); current congestive heart failure; history of cardiac arrhythmia (benign PACs and PVCs allowed). Subjects with asymptomatic coronary artery disease (e.g. CABG, stent placement or angioplasty) may participate if negative stress test within 1 year prior to screening and written clearance from Cardiologist documented.
Hematocrit \<38% or \>60% at screening
History of hepatitis B, hepatitis C, or HIV
Current treatment for a seizure disorder unless written clearance by neurologist to participate in study
History of adrenal insufficiency
Currently receiving (or likely to need during the study period): immunosuppressant therapy; chemotherapy; anticoagulant/antithrombotic therapy (excluding aspirin); topical glucocorticoids over sensor site only; antibiotics for chronic infection (e.g. osteomyelitis, endocarditis)
A condition requiring or likely to require magnetic resonance imaging (MRI)
Known topical or local anesthetic allergy
Known allergy to glucocorticoids
Any condition that in the investigator's opinion would make the subject unable to complete the study or would make it not in the subject's best interest to participate in the study. Conditions include but are not limited to psychiatric conditions, known current or recent alcohol abuse or drug abuse by subject history, a condition that may increase the risk of induced hypoglycemia or risk related to repeated blood testing. Investigator will supply rationale for exclusion
Participation in another clinical investigation (drug or device) within 2 weeks prior to screening or intent to participate during study period
The presence of another active implanted device\
\*An example of an active implanted device includes but is not limited to an implantable defibrillator. Passive implantable devices are allowed. An example of a passive implantable device includes, but is not limited to, a cardiac stent. The use of commercial transcutaneous CGM devices (e.g. Dexcom G6/G7 CGM and Abbott Libre) are allowed and not exclusionary. Note that FDA-approved Eversense CGM System (not study provided) use will not be allowed.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Renton?

Yes, this clinical trial (NCT07518004) has an active research site in Renton, WA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Diabetes Treatment Options in Renton, WA

If you're searching for diabetes treatment options in Renton, WA, this clinical trial (NCT07518004) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Renton research site is actively enrolling participants for this clinical trial. You'll receive care from experienced diabetes specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all diabetes clinical trials near you to find additional studies recruiting in your area.

More Essential Tremor Trials in Renton, WA

See all essential tremor clinical trials recruiting in Renton — not just this study.

Browse Essential Tremor Trials in Renton →

Browse More Trials by Condition

Essential Tremor TrialsType 2 Diabetes TrialsType 1 Diabetes TrialsGestational Diabetes TrialsDiabetic Kidney Disease TrialsJuvenile Diabetes TrialsAll Conditions →

Ready to Join in Renton?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Renton, WA